1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )MR imaging and spectroscopy data for individual patients affected by tetrahydrobiopterin deficiency
Patient No. MR Images Lactate Peak NAA:CRE NAA:CHO NAA:MI MI:CRE MI:CHO CHO:CRE Patient Age (yr) at MR Imaging Patient Age (yr) at IQ Test MR Image Phe (μmol/L) Average Phe (μmol/L) VIQ PIQ FSIQ Average Dosage (mg/kg/day) 5-HTP BH4 Levodopa 1 White matter T2 ↑ + 1.259 1.442 1.444 0.872 0.999 0.873 8.5 7.7 177 119 64 55 56 1.72 8.30 1.43 2 Negative − 1.553 ↑ 1.389 1.118 8.5 6.9 108 103 84 86 83 1.20 4.04 0.65* 3 Negative − 1.779 ↑ 1.500 1.888 0.942 0.794 1.186 8.5 6.9 99 69 58 64 57 1.74 7.84 1.21* 4 Prominent sulcation + 5.944 ↑ 10.30 ↑ 2.316 2.567 4.447 0.577 8 6.4 65 104 74 83 76 2.33 9.53 2.43 5 Prominent sulcation − 1.487 2.659 ↑ 0.799 1.860 3.328 0.559 5 5.3 45 104 78 82 78 2.92 10.53 2.19 6 Negative − 0.645 ↓ 0.681 ↓ 1.523 5 4.0 83 102 92 106 98 2.25 9.35 1.49 7 Negative − 1.692 ↑ 3.192 ↑ 4.577 0.370 0.697 0.530 5 3.6 6 106 80 95 92 1.94 9.02 2.64 8 Negative − 1.452 1.525 ↑ 1.248 1.163 1.222 0.952 4 74 62 2.31 9.42 2.07
Note.—NAA indicates N-acetylaspartate; CRE, creatine; CHO, choline; MI, myo-inositol; IQ, intelligence quotient; Phe, phenylalanine; VIQ, verbal intelligence quotient; PIQ, performance intelligence quotient; FSIQ, full-scale intelligence quotient; BH4, tetrahydrobiopterin; 5-HTP, 5-hydroxytryptophan.
↵* Patients 2 and 3 stopped 5-HTP supplementation at the ages of 7 and 6 years, respectively.